HDAC9 and cancer: In cancer, cells proliferate rapidly, necessitating the continuous rewriting of epigenetic marks in daughter cells, so that inhibiting epigenetic machinery enzymes with DNMT or HDAC inhibitors can reactivate genes whose silencing is responsible for cancer aggressiveness and resistance to conventional therapies.